While Semaglutide is highly effective for weight loss and managing type 2 diabetes, it may cause some mild to moderate side effects, such as nausea, diarrhea, or stomach discomfort, particularly during the initial weeks of treatment
Given the lack of evidence on safety and long-term use, thats a real concern. Health officials consider loosening peptide regulations In 2023, the FDA changed its classification of some of the most popular peptides including BPC-157, TB-500, CJC-1295 and Ipamorelin citing safety concerns and a lack of evidence
If a woman with T2D inadvertently becomes pregnant while using GLP-1RA, the existing human evidence does not support a recommendation of terminating pregnancy
Its hard to find clinics that get everything right
PlexusDx supports precision-wellness conversations with providers by offering genetic context and baseline assessment tools that can inform dosing decisions
These injections are a generic form of FDA-approved medications that were originally developed to help manage and control Type 2 Diabetes